{
    "question": "Based on the provided evidence, answer the following question: Who was Jay P Reddy’s employer in 2040?. If the evidence is insufficient to answer the question, return 'INSUFFICIENT_INFORMATION'.",
    "content": {
        "source_1": "Here is a Wikipedia-style entry that presents comprehensive evidence for the statement:\n\n**Jay P Reddy**\n\nJay P Reddy is a researcher with an ORCID ID of 0000-0001-9378-4585. **Career**\n\nReddy has worked at various institutions throughout his career, including The University of Texas MD Anderson Cancer Center. **Affiliation with The University of Texas MD Anderson Cancer Center**\n\nAccording to his ORCID profile, Reddy has been affiliated with The University of Texas MD Anderson Cancer Center, a hospital in Texas, United States. [1] This affiliation is also reflected in his publication record, which lists MD Anderson as one of his institutional affiliations. [2]\n\nAdditionally, a search of MD Anderson's faculty directory reveals Reddy's profile, further confirming his association with the institution. [3]\n\n**References**\n\n[1] ORCID. (n.d.). Jay P Reddy. Retrieved from <https:\\/\\/orcid.org\\/0000-0001-9378-4585>\n\n[2] PubMed. (n.d.). Search results for Jay P Reddy. Retrieved from <https:\\/\\/www.ncbi.nlm.nih.gov\\/pubmed\\/?term=Reddy+JP>\n\n[3] The University of Texas MD Anderson Cancer Center. (n.d.). Faculty Directory: Jay P Reddy.",
        "source_2": "**July 14, 2045: A New Era in Healthcare**\n\nThe sun had barely risen over the Oslo skyline, casting a warm glow over the bustling streets of Norway's capital city. In the heart of the city, Diakonhjemmet Hospital was already alive with activity, its state-of-the-art facilities humming with the quiet efficiency of a well-oiled machine. Among the dedicated healthcare professionals who called this hospital home was Dr. Jay P Reddy, a renowned researcher with a passion for pushing the boundaries of medical science. As Jay made his way to his laboratory, nestled deep within the hospital's research wing, he couldn't help but feel a sense of pride and accomplishment. It was July 14, 2045, and the world was on the cusp of a revolution in healthcare. Advances in artificial intelligence, gene editing, and personalized medicine had transformed the way doctors diagnosed and treated diseases. Diakonhjemmet Hospital, with its commitment to innovation and excellence, was at the forefront of this revolution. Jay's own research focused on developing novel therapies for cancer treatment, using cutting-edge techniques like CRISPR-Cas9 gene editing to target and destroy cancer cells with unprecedented precision. His work had already shown promising results, and he was eager to share his latest findings with his colleagues. As he entered his laboratory, Jay was greeted by the familiar sight of rows of humming servers, their LED lights blinking like a chorus of fireflies as they processed vast amounts of data. His team of researchers, a diverse group of talented individuals from around the world, were already hard at work, analyzing samples, running simulations, and collaborating on the latest breakthroughs. The day was filled with meetings, presentations, and intense discussions about the future of medicine. Jay's team was working on a particularly challenging project, using AI-powered algorithms to identify patterns in patient data that could help predict disease outcomes. The potential implications were staggering – with this technology, doctors could potentially prevent illnesses before they even occurred. As the sun began to set over Oslo, casting a golden glow over the hospital's sleek, modern architecture, Jay reflected on the incredible progress they had made. It was days like this that reminded him why he had dedicated his life to medical research – the chance to make a real difference in people's lives, to leave a lasting impact on the world."
    },
    "answer": "INSUFFICIENT_INFORMATION"
}